Middle East and Africa Compression Therapy Market
Market Report I 2025-09-01 I 350 Pages I Data Bridge Market Research
The Middle East and Africa compression therapy market is expected to reach USD 230,423.25 thousand by 2032 from USD 138,694.61 thousand in 2024, growing at a substantial CAGR of 6.6% in the forecast period of 2025 to 2032.
Market Segmentation:
Middle East and Africa Compression Therapy Market, By Product Technique (Static Compression Therapy and Dynamic Compression Therapy), Product Type (Compression Bandages, Garments For Lymphedema, Stockings For Venous Diseases, Compression Wraps, Pneumatic Compression Devices, and Compression Hosiery & Gauntlets), Application (Varicose Veins, Lymphedema, Chronic Venous Insufficiency (CVI), Deep Vein Thrombosis (DVT), Venous Leg Ulcers, Wound Care, and Sports Injury Management), Patient Group (Adult, Geriatric, and Pediatric), Compression Level (Moderate Compression, Strong Compression, Mild Compression, and Very Strong Compression), Distribution Channels (Hospital, Retail Pharmacies, Ecommerce Platforms, Specialty Clinics, Medical Device Stores, Home Healthcare Providers, and Nursing Homes/Long-Term Care Facilities), Country (Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, and rest of Middle East and Africa) - Industry Trends & Forecast To 2032
Overview of the Middle East and Africa Compression Therapy are:
Driver
- Increasing Sports Injuries & Accidents
Restrain
- Limited Reimbursement and Insurance Coverage
Opportunity
- Growth In Home Based Therapy
Market Players:
The key market players for Middle East and Africa Compression Therapy are listed below:
- Solventum (U.S.)
- Cardinal Health (U.S.)
- Smith+Nephew - (U.K.)
- Essity Aktiebolag (publ) (Sweden)
- PAUL HARTMANN AG (Germany)
- Zimmer Biomet (U.S.)
- NIKE, Inc. (U.S.)
- McKesson Medical-Surgical Inc. (U.S.)
- Getinge (Sweden)
- Convatec Group PLC (U.K.)
- Tactile Medical (U.S.)
- adidas AG (Germany)
- Enovis Corporation (U.S.)
- Molnlycke AB (Sweden)
- Lohmann & Rauscher GmbH & Co. KG (Germany)
- THUASNE, SAS (France)
- SIGVARIS GROUP - (Switzerland)
- Medline Industries, LP (U.S.)
- ThermoTek (U.S.)
- Mego Afek ltd. (Israel)
TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET 23
1.4 LIMITATIONS 25
1.5 MARKETS COVERED 25
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 CURRENCY AND PRICING 31
2.5 DBMR TRIPOD DATA VALIDATION MODEL 32
2.6 MULTIVARIATE MODELLING 35
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.8 DBMR MARKET POSITION GRID 37
2.9 MARKET APPLICATION COVERAGE GRID 38
2.10 VENDOR SHARE ANALYSIS 39
2.11 SECONDARY SOURCES 40
2.12 ASSUMPTIONS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 45
4.1 PESTAL ANALYSIS 47
4.2 PORTERS FIVE FORCES ANALYSIS 48
4.3 COST ANALYSIS BREAKDOWN 49
4.4 HEALTHCARE ECONOMY 50
4.4.1 HEALTHCARE EXPENDITURE 50
4.4.2 CAPITAL EXPENDITURE 50
4.4.3 CAPEX TRENDS 50
4.4.4 CAPEX ALLOCATION 50
4.4.5 FUNDING SOURCES 50
4.4.6 INDUSTRY BENCHMARKS 50
4.4.7 GDP RATIO IN OVERALL GDP 51
4.4.8 HEALTHCARE SYSTEM STRUCTURE 51
4.4.9 GOVERNMENT POLICIES 51
4.4.10 ECONOMIC DEVELOPMENT 51
4.5 INDUSTRY INSIGHTS 52
4.5.1 MICRO AND MACRO ECONOMIC FACTORS 52
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING 53
4.5.3 KEY PRICING STRATEGIES 54
4.6 INNOVATION TRACKER AND STRATEGIC ANALYSIS 55
4.6.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 55
4.6.1.1 JOINT VENTURES 55
4.6.1.2 MERGERS AND ACQUISITIONS 55
4.6.1.3 LICENSING AND PARTNERSHIP 55
4.6.1.4 TECHNOLOGY COLLABORATIONS 55
4.6.1.5 STRATEGIC DIVESTMENTS 55
4.6.2 NUMBER OF PRODUCTS IN DEVELOPMENT 55
4.6.3 STAGE OF DEVELOPMENT 56
4.6.4 TIMELINES AND MILESTONES 56
4.6.5 INNOVATION STRATEGIES AND METHODOLOGIES 56
4.6.6 RISK ASSESSMENT AND MITIGATION 56
4.6.7 FUTURE OUTLOOK 56
4.7 OPPORTUNITY MAP ANALYSIS 57
4.8 PATENT ANALYSIS - 58
4.8.1 PATENT QUALITY AND STRENGTH 58
4.8.2 PATENT FAMILIES 58
4.8.3 LICENSING AND COLLABORATIONS 59
4.8.4 COMPETITIVE LANDSCAPE 59
4.8.5 IP STRATEGY AND MANAGEMENT 60
4.8.6 OTHER OBSERVATIONS 60
4.9 REIMBURSEMENT FRAMEWORK 62
4.10 SUPPLY CHAIN ECOSYSTEM 63
4.10.1 PROMINENT COMPANIES 63
4.10.2 SMALL & MEDIUM SIZE COMPANIES 64
4.10.3 END USERS 64
4.11 TECHNOLOGY ROADMAP 65
4.12 TARIFFS & IMPACT ON THE MARKET 67
4.12.1 CURRENT TARIFF RATE(S) IN TOP-5 COUNTRY MARKETS 67
4.13 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 68
4.14 VENDOR SELECTION CRITERIA DYNAMICS 68
4.15 IMPACT ON SUPPLY CHAIN 69
4.15.1 RAW MATERIAL PROCUREMENT 69
4.15.2 MANUFACTURING AND PRODUCTION 69
4.15.3 LOGISTICS AND DISTRIBUTION 69
4.15.4 PRICE PITCHING AND POSITION OF MARKET 69
4.16 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 70
4.16.1 SUPPLY CHAIN OPTIMIZATION 70
4.16.2 JOINT VENTURE ESTABLISHMENTS 70
4.17 IMPACT ON PRICES 70
4.18 REGULATORY INCLINATION 70
4.18.1 GEOPOLITICAL SITUATION 70
4.18.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES 70
4.18.2.1 FREE TRADE AGREEMENTS: 70
4.18.2.2 ALLIANCES ESTABLISHMENTS: 70
4.18.3 STATUS ACCREDITATION (INCLUDING MFTN) 71
4.18.4 DOMESTIC COURSE OF CORRECTION 71
4.18.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS: 71
4.18.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS: 71
4.19 PRICE INDEX 71
5 REGULATORY FRAMEWORK 72
6 MARKET OVERVIEW 82
6.1 DRIVERS 84
6.1.1 RISING PREVALENCE OF CHRONIC VENOUS DISORDERS GLOBALLY 84
6.1.2 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATION 84
6.1.3 INCREASING SPORTS INJURIES & ACCIDENTS 85
6.1.4 INCREASING AWARENESS OF THERAPY BENEFITS 86
6.2 RESTRAINTS 87
6.2.1 LIMITED REIMBURSEMENT AND INSURANCE COVERAGE 87
6.2.2 AVAILABILITY OF ALTERNATIVE TREATMENT 88
6.3 OPPORTUNITIES 89
6.3.1 GROWTH IN HOME BASED THERAPY 89
6.3.2 POST-SURGICAL CARE & REHABILITATION 89
6.3.3 RISING LIFESTYLE-RELATED DISEASES 90
6.4 CHALLENGES 91
6.4.1 LACK OF STANDARDIZED THERAPY PROTOCOLS 91
6.4.2 ENSURING ACCURATE PRODUCT FIT AND CORRECT APPLICATION 92
7 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE 93
7.1 OVERVIEW 94
7.2 STATIC COMPRESSION THERAPY 97
7.2.1 COMPRESSION STOCKINGS 98
7.2.2 COMPRESSION BANDAGES 98
7.2.3 COMPRESSION SLEEVES 98
7.2.4 COMPRESSION WRAPS 98
7.2.5 COMPRESSION GLOVES/GAUNTLETS 98
7.3 DYNAMIC COMPRESSION THERAPY 99
7.3.1 PNEUMATIC COMPRESSION DEVICES 99
7.3.2 ADAPTIVE COMPRESSION THERAPY DEVICES 99
8 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET, BY PRODUCT TYPE 100
8.1 OVERVIEW 101
8.2 COMPRESSION BANDAGES 105
8.2.1 SHORT STRETCH BANDAGES 106
8.2.2 LONG STRETCH BANDAGES 106
8.2.3 MULTILAYER COMPRESSION BANDAGES 106
8.3 COMPRESSION GARMENTS FOR LYMPHEDEMA 107
8.3.1 LEG GARMENTS 108
8.3.2 ARM SLEEVES 108
8.3.3 HAND GLOVES 108
8.3.4 TORSO/TRUNK GARMENTS 108
8.3.5 FACE/HEAD GARMENTS 108
8.4 COMPRESSION STOCKINGS FOR VENOUS DISEASES 109
8.4.1 BELOW KNEE STOCKINGS 110
8.4.2 THIGH HIGH STOCKINGS 110
8.4.3 PANTYHOSE/FULL LEG STOCKINGS 110
8.4.4 MATERNITY STOCKINGS 110
8.5 COMPRESSION WRAPS 110
8.6 PNEUMATIC COMPRESSION DEVICES 111
8.7 COMPRESSION HOSIERY & GAUNTLETS 111
9 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET, BY APPLICATION 112
9.1 OVERVIEW 113
9.2 VARICOSE VEINS 117
9.3 LYMPHEDEMA 117
9.4 CHRONIC VENOUS INSUFFICIENCY (CVI) 118
9.5 DEEP VEIN THROMBOSIS (DVT) 118
9.6 VENOUS LEG ULCERS 119
9.7 WOUND CARE 119
9.8 SPORTS INJURY MANAGEMENT 120
10 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET, BY PATIENT GROUP 121
10.1 OVERVIEW 122
10.2 ADULT 125
10.3 GERIATRIC 126
10.4 PEDIATRIC 126
11 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL 127
11.1 OVERVIEW 128
11.2 MODERATE COMPRESSION 131
11.3 STRONG COMPRESSION 132
11.4 MILD COMPRESSION 133
11.5 VERY STRONG COMPRESSION 133
12 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS 134
12.1 OVERVIEW 135
12.2 HOSPITALS 139
12.2.1 BANDAGES 140
12.2.2 POST-OPERATIVE COMPRESSION STOCKINGS 140
12.2.3 PNEUMATIC COMPRESSION DEVICES 140
12.3 RETAIL PHARMACIES 140
12.3.1 MILD TO MODERATE COMPRESSION STOCKINGS 141
12.3.2 COMPRESSION BANDAGES 141
12.3.3 SLEEVES AND GAUNTLETS 141
12.4 ECOMMERCE PLATFORMS 142
12.4.1 COMPRESSION STOCKINGS & GARMENTS 143
12.4.2 COMPRESSION WRAPS 143
12.4.3 SLEEVES, GLOVES, AND SOCKS 143
12.4.4 PORTABLE PNEUMATIC DEVICES 143
12.5 SPECIALTY CLINICS 143
12.5.1 HIGH-PRESSURE COMPRESSION GARMENTS 144
12.5.2 PNEUMATIC COMPRESSION PUMPS 144
12.5.3 CUSTOM WRAPS 144
12.6 MEDICAL DEVICE STORES 145
12.6.1 COMPRESSION STOCKINGS 146
12.6.2 COMPRESSION BANDAGES 146
12.6.3 COMPRESSION WRAPS 146
12.6.4 PNEUMATIC COMPRESSION DEVICES 146
12.6.5 ADAPTIVE COMPRESSION SYSTEMS 146
12.7 HOME HEALTHCARE PROVIDERS 147
12.7.1 COMPRESSION WRAPS 148
12.7.2 SLEEVES & GARMENTS 148
12.7.3 BANDAGES 148
12.7.4 PNEUMATIC PUMPS (PORTABLE) 148
12.8 NURSING HOMES/LONG-TERM CARE FACILITIES 148
12.8.1 COMPRESSION WRAPS 149
12.8.2 SLEEVES AND GAUNTLETS 149
12.8.3 ADAPTIVE GARMENTS 149
13 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET, BY REGION 150
13.1 MIDDLE EAST AND AFRICA 152
13.1.1 SOUTH AFRICA 159
13.1.2 SAUDI ARABIA 165
13.1.3 EGYPT 171
13.1.4 U.A.E. 177
13.1.5 ISRAEL 183
13.1.6 KUWAIT 189
13.1.7 REST OF MIDDLE EAST AND AFRICA 195
14 MIDDLE EAST AND AFRICA COMPRESSION THERAPY MARKET: COMPANY LANDSCAPE 196
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 196
15 SWOT ANALYSIS 197
16 COMAPANY PROFILES 198
16.1 SOLVENTUM 198
16.1.1 COMPANY SNAPSHOT 198
16.1.2 REVENUE ANALYSIS 198
16.1.3 COMPANY SHARE ANALYSIS 199
16.1.4 PRODUCT PORTFOLIO 199
16.1.5 RECENT DEVELOPMENT 199
16.2 CARDINAL HEALTH 200
16.2.1 COMPANY SNAPSHOT 200
16.2.2 REVENUE ANALYSIS 200
16.2.3 COMPANY SHARE ANALYSIS 201
16.2.4 PRODUCT PORTFOLIO 201
16.2.5 RECENT DEVELOPMENT 202
16.3 SMITH+NEPHEW 203
16.3.1 COMPANY SNAPSHOT 203
16.3.2 REVENUE ANALYSIS 203
16.3.3 COMPANY SHARE ANALYSIS 204
16.3.4 PRODUCT PORTFOLIO 204
16.3.5 RECENT DEVELOPMENT 205
16.4 ESSITY AKTIEBOLAG (PUBL) 206
16.4.1 COMPANY SNAPSHOT 206
16.4.2 REVENUE ANALYSIS 206
16.4.3 COMPANY SHARE ANALYSIS 207
16.4.4 PRODUCT PORTFOLIO 207
16.4.5 RECENT DEVELOPMENT 209
16.5 PAUL HARTMANN AG 210
16.5.1 COMPANY SNAPSHOT 210
16.5.2 REVENUE ANALYSIS 210
16.5.3 COMPANY SHARE ANALYSIS 211
16.5.4 PRODUCT PORTFOLIO 211
16.5.5 RECENT DEVELOPMENT 211
16.6 ADIDAS AG 212
16.6.1 COMPANY SNAPSHOT 212
16.6.2 REVENUE ANALYSIS 212
16.6.3 PRODUCT PORTFOLIO 213
16.6.4 RECENT DEVELOPMENT 213
16.7 AIROS MEDICAL, INC. 214
16.7.1 COMPANY SNAPSHOT 214
16.7.2 PRODUCT PORTFOLIO 214
16.7.3 RECENT DEVELOPMENT 215
16.8 ARJO 216
16.8.1 COMPANY SNAPSHOT 216
16.8.2 REVENUE ANALYSIS 216
16.8.3 PRODUCT PORTFOLIO 217
16.8.4 RECENT DEVELOPMENTS 217
16.9 BAUERFEIND 218
16.9.1 COMPANY SNAPSHOT 218
16.9.2 PRODUCT PORTFOLIO 218
16.9.3 RECENT DEVELOPMENT 219
16.10 BIOCOMPRESSION SYSTEMS 220
16.10.1 COMPANY SNAPSHOT 220
16.10.2 PRODUCT PORTFOLIO 220
16.10.3 RECENT DEVELOPMENT 220
16.11 CALZE G.T.S.R.L 221
16.11.1 COMPANY SNAPSHOT 221
16.11.2 PRODUCT PORTFOLIO 221
16.11.3 RECENT DEVELOPMENT 222
16.12 CONVATEC GROUP PLC 223
16.12.1 COMPANY SNAPSHOT 223
16.12.2 PRODUCT PORTFOLIO 223
16.12.3 RECENT DEVELOPMENT 224
16.13 ENOVIS CORPORATION 225
16.13.1 COMPANY SNAPSHOT 225
16.13.2 REVENUE ANALYSIS 225
16.13.3 BRAND PORTFOLIO 226
16.13.4 RECENT DEVELOPMENTS 226
16.14 GETINGE 227
16.14.1 COMPANY SNAPSHOT 227
16.14.2 REVENUE ANALYSIS 227
16.14.3 PRODUCT PORTFOLIO 228
16.14.4 RECENT DEVELOPMENT 228
16.15 HUNTLEIGH HEALTHCARE LIMITED 229
16.15.1 COMPANY SNAPSHOT 229
16.15.2 PRODUCT PORTFOLIO 229
16.15.3 RECENT DEVELOPMENT 230
16.16 JUZO 231
16.16.1 COMPANY SNAPSHOT 231
16.16.2 PRODUCT PORTFOLIO 231
16.16.3 RECENT DEVELOPMENT 232
16.17 LOHMANN & RAUSCHER GMBH & CO. KG 233
16.17.1 COMPANY SNAPSHOT 233
16.17.2 PRODUCT PORTFOLIO 233
16.17.3 RECENT DEVELOPMENT 234
16.18 MCKESSON MEDICAL-SURGICAL INC. 235
16.18.1 COMPANY SNAPSHOT 235
16.18.2 REVENUE ANALYSIS 236
16.18.3 PRODUCT PORTFOLIO 236
16.18.4 RECENT DEVELOPMENT 237
16.19 MEDLINE INDUSTRIES, LP 238
16.19.1 COMPANY SNAPSHOT 238
16.19.2 PRODUCT PORTFOLIO 238
16.19.3 RECENT DEVELOPMENTS 239
16.20 MEDI GMBH & CO. KG 240
16.20.1 COMPANY SNAPSHOT 240
16.20.2 PRODUCT PORTFOLIO 240
16.20.3 RECENT DEVELOPMENT 241
16.21 MEGO AFEK LTD. 242
16.21.1 COMPANY SNAPSHOT 242
16.21.2 PRODUCT PORTFOLIO 242
16.21.3 RECENT DEVELOPMENT 244
16.22 MOLNLYCKE AB 245
16.22.1 COMPANY SNAPSHOT 245
16.22.2 PRODUCT PORTFOLIO 245
16.22.3 RECENT DEVELOPMENT 246
16.23 NIKE, INC. 247
16.23.1 COMPANY SNAPSHOT 247
16.23.2 REVENUE ANALYSIS 247
16.23.3 PRODUCT PORTFOLIO 248
16.23.4 RECENT DEVELOPMENT 248
16.24 OFA BAMBERG GMBH 249
16.24.1 COMPANY SNAPSHOT 249
16.24.2 PRODUCT PORTFOLIO 249
16.24.3 RECENT DEVELOPMENT 250
16.25 OSSUR 251
16.25.1 COMPANY SNAPSHOT 251
16.25.2 RECENT FINANCIALS 251
16.25.3 PRODUCT PORTFOLIO 252
16.25.4 RECENT DEVELOPMENT 253
16.26 SIGVARIS GROUP 254
16.26.1 COMPANY SNAPSHOT 254
16.26.2 PRODUCT PORTFOLIO 254
16.26.3 RECENT DEVELOPMENT 254
16.27 TACTILE MEDICAL 255
16.27.1 COMPANY SNAPSHOT 255
16.27.2 REVENUE ANALYSIS 255
16.27.3 PRODUCT PORTFOLIO 256
16.27.4 RECENT DEVELOPMENT 256
16.28 THERMOTEK 258
16.28.1 COMPANY SNAPSHOT 258
16.28.2 PRODUCT PORTFOLIO 258
16.28.3 RECENT DEVELOPMENT 258
16.29 THUASNE, SAS 259
16.29.1 COMPANY SNAPSHOT 259
16.29.2 PRODUCT PORTFOLIO 259
16.29.3 RECENT DEVELOPMENT 259
16.30 ZIMMER BIOMET 260
16.30.1 COMPANY SNAPSHOT 260
16.30.2 REVENUE ANALYSIS 261
16.30.3 PRODUCT PORTFOLIO 261
16.30.4 RECENT DEVELOPMENTS 262
17 QUESTIONNAIRE 263
18 RELATED REPORTS 267
?
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.